Cerebral amyloid angiopathy is a cerebrovascular disease.It is characterized by the accumulation of amyloid in small blood vessels in leptomeninges and cerebral cortex.Advance in neuroimaging technology has made prenatal diagnosis of cerebral amyloid angiopathy the most widely used test in the world.However,the accuracy of neuroimaging in the detection of early cerebral amyloid angiopathy is limited,and many studies in recent years have been looking for reliable biomarkers in the diagnosis of early amyloid angiopathy,which will help in early diagnosis of cerebral amyloid angiopathy and ensure early detection,early diagnosis,and early treatment.This article reviews application progress of biomarkers in the diagnosis and treatment of cerebral amyloidosis.
维普
万方数据